β-Hydroxybutyrate: A Signaling Metabolite

Annual Review of Nutrition

Volumn 37, Issue , 2017, Pages 51-76

  Newman, John C ^a,b,c   Verdin, Eric ^a,b,c  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b GLADSTONE INSTITUTES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Epigenetics; Fasting; Ketone bodies; Metabolism

Indexed keywords

3 HYDROXYBUTYRIC ACID;

AGING; ANIMAL; GENETIC EPIGENESIS; HUMAN; LIVER; METABOLISM; SIGNAL TRANSDUCTION; STARVATION;

3-HYDROXYBUTYRIC ACID; AGING; ANIMALS; EPIGENESIS, GENETIC; HUMANS; LIVER; SIGNAL TRANSDUCTION; STARVATION;

EID: 85028000671     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071816-064916     Document Type: Review

References (163)

1. Anderson KA, Green MF, Huynh FK, Wagner GR, Hirschey MD. 2014. Snap Shot: Mammalian sirtuins. Cell 159(4):956-956.e1
2. Ang ZW, Er JZ, Tan NS, Lu JH, Liou YC, et al. 2016. Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci. Rep. 6:34145
3. Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E. 2009. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150:4931-40
4. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. 2007. Hepatic fibroblast growth factor 21 is regulated by PPAR? and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5:426-37
5. Balietti M, Casoli T, Di Stefano G, Giorgetti B, Aicardi G, Fattoretti P. 2010. Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain. Ageing Res. Rev. 9:273-79
6. Barton KM, Palmer SE. 2016. How to define the latent reservoir: Tools of the trade. Curr. HIV/AIDS Rep. 13:77-84
7. Berg JM, Tymoczko JL, Stryer L. 2012. Biochemistry. New York: Freeman
8. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, et al. 2010. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18:436-47
9. Blad CC, Tang C, Offermanns S. 2012. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat. Rev. Drug Discov. 11:603-19
10. Boden G. 2011. Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 18:139-43
11. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-19
12. Cahill GF Jr. 2006. Fuel metabolism in starvation. Annu. Rev. Nutr. 26:1-22
13. Cahill GF Jr., Herrera MG, Morgan AP, Soeldner JS, Steinke J, et al. 1966. Hormone-fuel interrelationships during fasting. J. Clin. Investig. 45:1751-69
14. Chen YF, Du JF, Zhao YT, Zhang L, Lv GR, et al. 2015. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc. Diabetol. 14:99
15. Coll RC, O'Neill LAJ, Schroder K. 2016. Questions and controversies in innate immune research:What is the physiological role of NLRP3? Cell Death Discov. 2:16019
16. Dahlin M, Elfving A, Ungerstedt U, Amark P. 2005. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 64:115-25
17. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, et al. 2014. Microbiotagenerated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84-96
18. Dedkova EN, Blatter LA. 2014. Role of ?-hydroxybutyrate, its polymer poly-?-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease. Front. Physiol. 5:260
19. Desrochers S, Dubreuil P, Brunet J, Jette M, David F, et al. 1995. Metabolism of (R, S)-1, 3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs.Am. J. Physiol. 268:E660-67
20. Dobbins R, Byerly R, Gaddy R, Gao F, Mahar K, et al. 2015. GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial. Eur. J. Pharmacol. 755:95-101
21. Dobbins RL, Shearn SP, Byerly RL, Gao FF, Mahar KM, et al. 2013. GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus. Diabetes Obes. Metab. 15:1013-21
22. Donevan SD, White HS, Anderson GD, Rho JM. 2003. Voltage-dependent block of N-methyl-Daspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-?-hydroxybutyrate. Epilepsia 44:1274-79
23. Dovey OM, Foster CT, Cowley SM. 2010. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. PNAS 107:8242-47
24. Edwards C, Canfield J, Copes N, Rehan M, Lipps D, Bradshaw PC. 2014. D-beta-hydroxybutyrate extends lifespan in C. Elegans. Aging 6:621-44
25. Erecinska M, Nelson D, Daikhin Y, Yudkoff M. 1996. Regulation of GABA level in rat brain synaptosomes: Fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J. Neurochem. 67:2325-34
26. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, et al. 2002. The retinoblastoma-histone deacetylase 3 complex inhibits PPAR?and adipocyte differentiation. Dev. Cell 3:903-10
27. Feldman N, Rotter-Maskowitz A, Okun E. 2015. DAMPs as mediators of sterile inflammation in agingrelated pathologies. Ageing Res. Rev. 24:29-39
28. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH. 2007. Recovery of learning and memory is associated with chromatin remodelling. Nature 447:178-82
29. Freeman LC, Ting JPY. 2016. The pathogenic role of the inflammasome in neurodegenerative diseases. J. Neurochem. 136:29-38
30. Gaidarov I, Chen XH, Anthony T, Maciejewski-Lenoir D, Liaw C, Unett DJ. 2013. Differential tissue and ligand-dependent signaling of GPR109A receptor: Implications for anti-atherosclerotic therapeutic potential. Cell. Signal. 25:2003-16
31. Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, et al. 2013. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 62:732-42
32. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, et al. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509-17
33. Gertz M, Steegborn C. 2010. The lifespan-regulator p66Shc in mitochondria: Redox enzyme or redox sensor? Antioxid. Redox Signal. 13:1417-28
34. Glozak MA, Sengupta N, Zhang X, Seto E. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363:15-23
35. Gold M, El Khoury J. 2015. ?-amyloid, microglia, and the inflammasome in Alzheimer's disease. Semin. Immunopathol. 37:607-11
36. Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, et al. 2017. ?-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 18:2077-87
37. Goldberg EL, Dixit VD. 2015. Drivers of age-related inflammation and strategies for healthspan extension. Immunol. Rev. 265:63-74
38. Graff EC, Fang H, Wanders D, Judd RL. 2016. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metab. Clin. Exp. 65:102-13
39. Graff J, Rei D, Guan JS, Wang WY, Seo J, et al. 2012. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483:222-26
40. Graff J, Tsai LH. 2013. Histone acetylation: Molecular mnemonics on the chromatin. Nat. Rev. Neurosci. 14:97-111
41. Gregoretti IV, Lee YM, Goodson HV. 2004. Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J. Mol. Biol. 338:17-31
42. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, et al. 2009.HDAC2negatively regulates memory formation and synaptic plasticity. Nature 459:55-60
43. Gut P, Verdin E. 2013. The nexus of chromatin regulation and intermediary metabolism. Nature 502:489-98
44. Hakre S, Chavez L, Shirakawa K, Verdin E. 2012. HIV latency: Experimental systems and molecular models. FEMS Microbiol. Rev. 36:706-16
45. Haneklaus M, O'Neill LAJ. 2015. NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 265:53-62
46. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392-95
47. Hartman AL, Gasior M, Vining EPG, Rogawski MA. 2007. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 36:281-92
48. He W, Newman JC, Wang MZ, Ho L, Verdin E. 2012. Mitochondrial sirtuins: Regulators of protein acylation and metabolism. Trends Endocrinol. Metab. 23:467-76
49. Hegardt FG. 1999. Mitochondrial 3-hydroxy-3-methylglutaryl-Co A synthase: A control enzyme in ketogenesis. Biochem. J. 338 (Pt. 3):569-82
50. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, et al. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493:674-78
51. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, et al. 2010. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121-25
52. Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DY, Schlegel A. 2012. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev. 26:282-93
53. Imai SI, Guarente L. 2014. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24:464-71
54. Jing H, Lin HN. 2015. Sirtuins in epigenetic regulation. Chem. Rev. 115:2350-75
55. Johnson SC, Rabinovitch PS, Kaeberlein M. 2013. m TOR is a key modulator of ageing and age-related disease. Nature 493:338-45
56. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, et al. 2010. Metabolic control of vesicular glutamate transport and release. Neuron 68:99-112
57. Kaeberlein M. 2010. Lessons on longevity from budding yeast. Nature 464:513-19
58. Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, et al. 2013. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol. Aging 34:1530-39
59. Kenyon CJ. 2010. The genetics of ageing. Nature 464:504-12
60. Kim DY, Rho JM. 2008. The ketogenic diet and epilepsy. Curr. Opin. Clin. Nutr.Metab. Care 11:113-20
61. Kim S, Benguria A, Lai CY, Jazwinski SM. 1999. Modulation of life-span by histone deacetylase genes in Saccharomyces cerevisiae. Mol. Biol. Cell 10:3125-36
62. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, et al. 2011. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). PNAS 108:8030-35
63. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. 2008. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27:1017-28
64. Koeslag JH, Noakes TD, Sloan AW. 1980. Post-exercise ketosis. J. Physiol. 301:79-90
65. Krebs HA, Gascoyne T. 1968. The redox state of the nicotinamide-adenine dinucleotides in rat liver homogenates. Biochem. J. 108:513-20
66. Laeger T, Metges CC, Kuhla B. 2010. Role of ?-hydroxybutyric acid in the central regulation of energy balance. Appetite 54:450-55
67. Landgrave-Gomez J, Mercado-Gomez O, Guevara-Guzman R. 2015. Epigenetic mechanisms in neurological and neurodegenerative diseases. Front. Cell. Neurosci. 9:58
68. Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HWM, et al. 2015. The epigenetics of aging and neurodegeneration. Prog. Neurobiol. 131:21-64
69. Lauring B, Taggart AKP, Tata JR, Dunbar R, Caro L, et al. 2012. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Sci. Transl. Med. 4:148ra115
70. Layden BT, Angueira AR, Brodsky M, Durai V, Lowe WL Jr. 2013. Short chain fatty acids and their receptors: New metabolic targets. Transl. Res.: J. Lab. Clin. Med. 161:131-40
71. Le Roith D, Taylor SI, Olefsky JM. 2004. Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia: Lippincott Williams &Wilkins
72. Li H, Gao Z, Zhang J, Ye X, Xu A, et al. 2012. Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. Diabetes 61:797-806
73. Li L, Shi L, Yang SD, Yan RR, Zhang D, et al. 2016. SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability. Nat. Commun. 7:12235
74. Lincoln BC, Des Rosiers C, Brunengraber H. 1987. Metabolism of S-3-hydroxybutyrate in the perfused rat liver. Arch. Biochem. Biophys. 259:149-56
75. Longo VD, Panda S. 2016. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab. 23:1048-59
76. Lund TM, Ploug KB, Iversen A, Jensen AA, Jansen-Olesen I. 2015. The metabolic impact of ?-hydroxybutyrate on neurotransmission: Reduced glycolysis mediates changes in calcium responses and KATP channel receptor sensitivity. J. Neurochem. 132:520-31
77. Lutas A, Birnbaumer L, Yellen G. 2014. Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels. J. Neurosci. 34:16336-47
78. Ma WY, Berg J, Yellen G. 2007. Ketogenic diet metabolites reduce firing in central neurons by opening KATP channels. J. Neurosci. 27:3618-25
79. Macia L, Tan J, Vieira AT, Leach K, Stanley D, et al. 2015. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6:6734
80. Madiraju P, Pande SV, Prentki M, Madiraju SR. 2009. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenet.: Off. J. DNA Methylation Soc. 4:399-403
81. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, et al. 2013. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4:2192
82. Mattson MP, Longo V, Harvie M. 2016. Impact of intermittent fasting on health and disease processes. Ageing Res. Rev. pii:S1568-1637(16)30251-3
83. Mc Nally MA, Hartman AL. 2012. Ketone bodies in epilepsy. J. Neurochem. 121:28-35
84. Melo TM, Nehlig A, Sonnewald U. 2006. Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem. Int. 48:498-507
85. Mihaylova MM, Shaw RJ. 2013. Metabolic reprogramming by class I and II histone deacetylases. Trends Endocrinol. Metab. 24:48-57
86. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, et al. 2011. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145:607-21
87. Milman S, Atzmon G, Huffman DM, Wan JX, Crandall JP, et al. 2014. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13:769-71
88. Morales CR, Li DL, Pedrozo Z, May HI, Jiang N, et al. 2016. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent m TOR repression. Sci. Signal. 9:ra34
89. Muoio DM, Noland RC, Kovalik JP, Seiler SE, Davies MN, et al. 2012. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 15:764-77
90. New M, Olzscha H, La Thangue NB. 2012. HDAC inhibitor-based therapies: Can we interpret the code? Mol. Oncol. 6:637-56
91. Newman JC, Milman S, Hashmi SK, Austad SN, Kirkland JL, et al. 2016. Strategies and challenges in clinical trials targeting human aging. J. Gerontol. A Biol. Sci. Med. Sci. 71:1424-34
92. Newman JC, Verdin E. 2014. Ketone bodies as signalingmetabolites. Trends Endocrinol. Metab. 25:42-52
93. Newport MT, Van Itallie TB, Kashiwaya Y, King MT, Veech RL. 2015. A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease. Alzheimer's Dement. 11:99-103
94. Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, et al. 2015. Expression of the short chain fatty acid receptor Gpr41/Ffar3 in autonomic and somatic sensory ganglia. Neuroscience 290:126-37
95. Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, IJzerman AP. 2011. International union of basic and clinical pharmacology. LXXXII: Nomenclature and classification of hydroxy-carboxylic acid receptors (GPR81, GPR109A, and GPR109B). Pharmacol. Rev. 63:269-90
96. Offermanns S, Schwaninger M. 2015. Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation. Trends Mol. Med. 21:245-55
97. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, et al. 2007. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: A circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27:5903-14
98. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, et al. 2010. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753-56
99. Pellerin L, Bergersen LH, Halestrap AP, Pierre K. 2005. Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J. Neurosci. Res. 79:55-64
100. Penney J, Tsai LH. 2014. Histone deacetylases in memory and cognition. Sci. Signal. 7:re12
101. Quant PA, Tubbs PK, Brand MD. 1989. Treatment of rats with glucagon or mannoheptulose increases mitochondrial 3-hydroxy-3-methylglutaryl-Co A synthase activity and decreases succinyl-Co A content in liver. Biochem. J. 262:159-64
102. Quant PA, Tubbs PK, Brand MD. 1990. Glucagon activates mitochondrial 3-hydroxy-3-methylglutaryl-Co A synthase in vivo by decreasing the extent of succinylation of the enzyme. Eur. J. Biochem. 187:169-74
103. Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, et al. 2014. The?-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun. 5:3944
104. Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, et al. 2013. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18:920-33
105. Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, et al. 2013. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. PNAS 110:6601-6
106. Rezq S, Abdel-Rahman AA. 2016. Central GPR109A activation mediates glutamate-dependent pressor response in conscious rats. J. Pharmacol. Exp. Ther. 356:456-65
107. Rho JM. 2015. How does the ketogenic diet induce anti-seizure effects? Neurosci. Lett. 637:4-10
108. Robinson AM, Williamson DH. 1980. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 60:143-87
109. Rogina B, Helfand SL. 2004. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. PNAS 101:15998-6003
110. Rogina B, Helfand SL, Frankel S. 2002. Longevity regulation by Drosophila Rpd3 deacetylase and caloric restriction. Science 298:1745
111. Roopra A, Dingledine R, Hsieh J. 2012. Epigenetics and epilepsy. Epilepsia 53:2-10
112. Roy M, Beauvieux MC, Naulin J, El Hamrani D, Gallis JL, et al. 2015. Rapid adaptation of rat brain and liver metabolism to a ketogenic diet: An integrated study using 1H-and 13C-NMR spectroscopy. J. Cereb. Blood Flow Metab. 35:1154-62
113. Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, et al. 2012. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. PNAS 109:E2895-903
114. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, et al. 1995. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9:651-58
115. Sekhavat A, Sun JM, Davie JR. 2007. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem. Cell Biol. 85:751-58
116. Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. 2010. m TORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468:1100-4
117. Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, et al. 2010. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl Co A synthase 2 and regulates ketone body production. Cell Metab. 12:654-61
118. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, et al. 2013. Suppression of oxidative stress by ?-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211-14
119. Sincennes MC, Brun CE, Rudnicki MA. 2016. Concise review: Epigenetic regulation of myogenesis in health and disease. Stem Cells Transl. Med. 5:282-90
120. Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, et al. 2016. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body ?-hydroxybutyrate. e Life pii:e15092
121. Someya S, Yu W, Hallows WC, Xu JZ, Vann JM, et al. 2010. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:802-12
122. Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, et al. 2004. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12:1325-34
123. Stein LR, Imai S. 2012. The dynamic regulation of NAD metabolism inmitochondria. Trends Endocrinol. Metab. 23:420-28
124. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, et al. 2005. (D)-?-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 280:26649-52
125. Tang C, Ahmed K, Gille A, Lu S, Grone HJ, et al. 2015. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21:85-89
126. Thio LL, Wong M, Yamada KA. 2000. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54:325-31
127. Thumelin S, Forestier M, Girard J, Pegorier JP. 1993. Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-Co A synthase gene expression in rat liver, intestine and kidney. Biochem. J. 292(Pt. 2):493-96
128. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, et al. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:159-66
129. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, et al. 2003. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 9:352-55
130. Vannini A, Volpari C, Filocamo G, Casavola EC, Brunetti M, et al. 2004. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexedwith a hydroxamic acid inhibitor. PNAS 101:15064-69
131. Veech RL. 2004. The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: Ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids 70:309-19
132. Veprik A, Laufer D, Weiss S, Rubins N, Walker MD. 2016. GPR41modulates insulin secretion and gene expression in pancreatic ?-cells and modifies metabolic homeostasis in fed and fasting states. FASEB J. 30:3860-69
133. Verdin E. 2015. NAD+ in aging, metabolism, and neurodegeneration. Science 350:1208-13
134. Verret L, Mann EO, Hang GB, Barth AM, Cobos I, et al. 2012. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149:708-21
135. von Meyenn F, Porstmann T, Gasser E, Selevsek N, Schmidt A, et al. 2013. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab. 17:436-47
136. Vossel KA, Beagle AJ, Rabinovici GD, Shu HD, Lee SE, et al. 2013. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 70:1158-66
137. Wang DF, Helquist P, Wiech NL, Wiest O. 2005. Toward selective histone deacetylase inhibitor design: Homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases. J. Med. Chem. 48:6936-47
138. Webber RJ, Edmond J. 1977. Utilization of L(+)-3-hydroxybutyrate, D(-)-3-hydroxybutyrate, acetoacetate, and glucose for respiration and lipid synthesis in the 18-day-old rat. J. Biol. Chem. 252:5222-26
139. Weinert BT, Scholz C, Wagner SA, Iesmantavicius V, Su D, et al. 2013. Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 4:842-51
140. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076-80
141. Wilting RH, Yanover E, Heideman MR, Jacobs H, Horner J, et al. 2010. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 29:2586-97
142. Winesett SP, Bessone SK, Kossoff EHW. 2015. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev. Neurother. 15:621-28
143. Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432:1027-32
144. Wolfrum C, Besser D, Luca E, Stoffel M. 2003. Insulin regulates the activity of forkhead transcription factor Hnf-3?/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. PNAS 100:11624-29
145. Won YJ, Lu VB, Puhl HL 3rd, Ikeda SR. 2013. ?-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3. J. Neurosci. 33:19314-25
146. Xie ZY, Dai JBA, Dai LZ, Tan MJ, Cheng ZY, et al. 2012. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteom. 11:100-7
147. Xie ZY, Zhang D, Chung DJ, Tang ZY, Huang H, et al. 2016. Metabolic regulation of gene expression by histone lysine ?-hydroxybutyrylation. Mol. Cell 62:194-206
148. Yamamoto I, Absalom N, Carland JE, Doddareddy MR, Gavande N, et al. 2012. Differentiating enantioselective actions of GABOB: A possible role for threonine 244 in the binding site of GABAC ?1 receptors. ACS Chem. Neurosci. 3:665-73
149. Yang L, Zhao J, Milutinovic PS, Brosnan RJ, Eger EI, Sonner JM. 2007. Anesthetic properties of the ketone bodies ss-hydroxybutyric acid and acetone. Anesthesia Analgesia 105:673-79
150. Yang XJ, Seto E. 2008. The Rpd3/Hda1 family of lysine deacetylases: From bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9:206-18
151. Yi C, Ma M, Ran L, Zheng J, Tong J, et al. 2012. Function and molecular mechanism of acetylation in autophagy regulation. Science 336:474-77
152. Yoshino J, Mills KF, Yoon MJ, Imai S. 2011. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab. 14:528-36
153. Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, et al. 2015. The ketone metabolite ?-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat.Med. 21:263-69
154. Yudkoff M, Daikhin Y, Melo TM, Nissim I, Sonnewald U, Nissim I. 2007. The ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect. Annu. Rev. Nutr. 27:415-30
155. Yudkoff M, Daikhin Y, Nissim I, Grunstein R, Nissim I. 1997. Effects of ketone bodies on astrocyte amino acid metabolism. J. Neurochem. 69:682-92
156. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I. 2001. Brain amino acid metabolism and ketosis. J. Neurosci. Res. 66:272-81
157. Zeng Z, Liao R, Yao Z, Zhou W, Ye P, et al. 2014. Three single nucleotide variants of the HDAC gene are associated with type 2 diabetes mellitus in a Chinese population: A community-based case-control study. Gene 533:427-33
158. Zhang D, Yang H, Kong X, Wang K, Mao X, et al. 2011. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 300:E287-95
159. Zhang HB, Ryu D, Wu YB, Gariani K, Wang X, et al. 2016. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352:1436-43
160. Zhang L, Qin X, Zhao Y, Fast L, Zhuang SG, et al. 2012. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J. Pharmacol. Exp. Ther. 341:285-93
161. Zhang Y, Xie Y, Berglund ED, Coate KC, He TT, et al. 2012. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. e Life 1:e00065
162. Zhao Y, Sun H, Lu J, Li X, Chen X, et al. 2005. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. J. Exp. Biol. 208:697-705
163. Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, et al. 2007. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67:9047-54